Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-11

Clinical Trial Update: Effect of Teleprevir in Triple Therapy on Intrahepatic Immunological Mechanisms

View source ↗

Summary

A completed clinical trial evaluated telaprevir-based triple therapy (telaprevir + pegylated interferon + ribavirin) and its impact on intrahepatic immunologica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Peginterferon alfa-2a (peginterferon alfa-2a)
  • Ribavirin (ribavirin)
  • Telaprevir (telaprevir)

Snippet

Sponsor: Foundation for Liver Research | Conditions: Chronic Hepatitis C | Status: COMPLETED